Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Oct;31(9):1675-81.
doi: 10.3174/ajnr.A2128. Epub 2010 May 20.

Regional distribution and clinical correlates of white matter structural damage in Huntington disease: a tract-based spatial statistics study

Affiliations

Regional distribution and clinical correlates of white matter structural damage in Huntington disease: a tract-based spatial statistics study

R Della Nave et al. AJNR Am J Neuroradiol. 2010 Oct.

Abstract

Background and purpose: HD entails damage of the WM. Our aim was to explore in vivo the regional volume and microstructure of the brain WM in HD and to correlate such findings with clinical status of the patients.

Materials and methods: Fifteen HD gene carriers in different clinical stages of the disease and 15 healthy controls were studied with T1-weighted images for VBM and DTI for TBSS. Maps of FA, MD, and λ∥ and λ⊥ were reconstructed.

Results: Compared with controls, in addition to neostriatum and cortical GM volume loss, individuals with HD showed volume loss in the genu of the internal capsule and subcortical frontal WM bilaterally, the right splenium of the corpus callosum, and the left corona radiata. TBSS revealed symmetrically decreased FA in the corpus callosum, fornix, external/extreme capsule, inferior fronto-occipital fasciculus, and inferior longitudinal fasciculus. Areas of increased MD were more extensive and included arciform fibers of the cerebral hemispheres and cerebral peduncles. Increase of the λ∥ and a comparatively more pronounced increase of the λ⊥ underlay the decreased FA of the WM in HD. Areas of WM atrophy, decreased FA, and increased MD correlated with the severity of the motor and cognitive dysfunction, whereas only the areas with increased MD correlated with disease duration.

Conclusions: Microstructural damage accompanies volume decrease of the WM in HD and is correlated with the clinical deficits and disease duration. MR imaging-based measures could be considered as a biomarker of neurodegeneration in HD gene carriers.

PubMed Disclaimer

Figures

Fig 1.
Fig 1.
A−T, TBSS analysis of FA maps. Maps of the t-value (t > 3 with P < .05 corrected for multiple comparisons) show, in red, the areas of significantly reduced FA in WM tracts in HD gene carriers compared with controls. These include the corpus callosum and the external/extreme capsule bilaterally (color bar indicates P values).
Fig 2.
Fig 2.
A−T, TBSS correlation results in HD gene carriers. Green shows the areas where MD correlates (t > 3 with P < .05 corrected for multiple comparisons) with the disease duration (color bar indicates P values).

Similar articles

Cited by

References

    1. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosome: The Huntington's Disease Collaborative Research Group. Cell 1993; 72: 971– 83 - PubMed
    1. de la Monte SM, Vonsattel JP, Richardson EP, Jr. Morphometric demonstration of atrophic changes in the cerebral cortex, white matter, and neostriatum in Huntington's disease. J Neuropathol Exp Neurol 1988; 47: 516– 25 - PubMed
    1. Thieben MJ, Duggins AJ, Good CD, et al. . The distribution of structural neuropathology in pre-clinical Huntington's disease. Brain 2002; 125: 1815– 28 - PubMed
    1. Beglinger LJ, Nopoulos PC, Jorge RE, et al. . White matter volume and cognitive dysfunction in early Huntington's disease. Cogn Behav Neurol 2005; 18: 102– 07 - PubMed
    1. Ciarmiello A, Cannella M, Lastoria S, et al. . Brain white-matter volume loss and glucose hypometabolism precede the clinical symptoms of Huntington's disease. J Nucl Med 2006; 47: 215– 22 - PubMed